ACE and COVID-19: In fact, although initial epidemiological studies showed that medication with ARBs or ACE inhibitors did not affect infectivity of SARS-CoV-2 and severity of COVID-19 in the patients42–44, recent clinical studies have suggested that ARBs or ACE inhibitors provide a good prognosis to the patients28,29.